![Trastuzumab deruxtecan [1826843-81-5] Trastuzumab deruxtecan [1826843-81-5]](https://www.targetmol.com/group3/M00/13/3F/CgoaEWZGsC-EMZXLAAAAAGmF318014.png)
Trastuzumab deruxtecan [1826843-81-5]

T36646
CAS Number1826843-81-5
Product group Chemicals
Estimated PuritySEC-HPLC:98.49%
Molecular WeightApproximately 45.42 kDa
Overview
- SupplierTargetMol Chemicals
- Product NameTrastuzumab deruxtecan
- Delivery Days Customer10
- CAS Number1826843-81-5
- Category SupplierChemical
- CertificationResearch Use Only
- Chemical NameTrastuzumab deruxtecan
- Estimated PuritySEC-HPLC:98.49%
- Molecular WeightApproximately 45.42 kDa
- Scientific DescriptionTrastuzumab deruxtecan (T-DXd) is an antibody-active molecule conjugate (ADC) with anticancer and antitumor activity, which is composed of a monoclonal antibody targeting human epidermal growth factor receptor 2 (HER2) coupled to a topoisomerase I inhibitor (DXd). Trastuzumab deruxtecan has an improved effect on the treatment of HER2-positive breast cancer and gastric cancer.
- Shelf life instruction3 years
- Storage Instruction-20°C
- UNSPSC12352203